Funding for this research was provided by:
Janssen Pharmaceuticals (N/A)
Received: 5 February 2020
Accepted: 24 August 2020
First Online: 1 September 2020
Ethics approval and consent to participate
: The research protocol was reviewed by Quorum Review Independent Review Board (Seattle, WA) and received exemption determination (February 2018). Participants contributing data through the social media platform provided consent when creating their account.
: Consent for publication given during the informed consent. Individual qualitative data de-identified.
: The authors are employees of Janssen Pharmaceutical.